Fig. 1.

HDACi treatments enhance the genes involved in antigen processing and presentation via MHC class I pathway in tumor cells. a B16F10, b B16F0 and c Colon 26 cells were treated with TSA (250 nM) or IFN-γ (100 U/ml) and mRNA for H-2D, TAP1, TAP2, LMP2, LMP7 and Tapasin was amplified by RT-PCR at 24 h. The data presented represent more than three independent experiments